BD begins shipments of smartphone interpreted, OTC rapid COVID-19 test

October 26, 2021  –  BD (Becton, Dickinson and Company) (Franklin Lakes, NJ) announced it has started to ship the first over-the-counter (OTC) COVID-19 rapid antigen test to use computer vision technology in a smartphone to interpret testing results.

The BD Veritor At-Home COVID-19 Test uses the Scanwell Health mobile app to interpret and provide a digital display of testing results in 15 minutes. The company says the test is one of the only at-home tests to fully automate reporting of results to federal and state public health agencies and provide a streamlined experience for optional reporting to businesses and schools.

The BD Veritor At-Home COVID-19 Test comes with two tests in each box for a manufacturer’s suggested retail price of $39.99.

It is currently available for purchase at for $26.50 through December to U.S. customers, as part of its partnership with the U.S. government. 

The test is also available for businesses, governments and schools through traditional BD sales channels. The new at-home test is an option for businesses, enterprises and schools looking to provide a self-testing method for employees or students, the company says.

The BD Veritor At-Home COVID-19 Test has not been FDA cleared or approved; but has been authorized by FDA under Emergency Use Authorization (EUA).

Learn More